313 related articles for article (PubMed ID: 26229583)
1. Expression of cdk4 and p16 in Oral Lichen Planus.
Goel S; Khurana N; Marwah A; Gupta S
J Oral Maxillofac Res; 2015; 6(2):e4. PubMed ID: 26229583
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of cdk4 and p16 in oral lichen planus supports the concept of premalignancy.
Poomsawat S; Buajeeb W; Khovidhunkit SO; Punyasingh J
J Oral Pathol Med; 2011 Apr; 40(4):294-9. PubMed ID: 21426400
[TBL] [Abstract][Full Text] [Related]
3. Effects of Mycophenolate Mofetil, Methotrexate and Pimecrolimus on cdk4 and p16 in Erosive Oral Lichen Planus.
Goel S; Khurana N
Indian J Dermatol; 2021; 66(5):490-495. PubMed ID: 35068503
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical Study of p53 Expression in Patients with Erosive and Non-Erosive Oral Lichen Planus.
Shiva A; Zamanian A; Arab S; Boloki M
J Dent (Shiraz); 2018 Jun; 19(2):118-123. PubMed ID: 29854885
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical expression of p16 protein in oral squamous cell carcinoma and lichen planus.
Salehinejad J; Sharifi N; Amirchaghmaghi M; Ghazi N; Shakeri MT; Ghazi A
Ann Diagn Pathol; 2014 Aug; 18(4):210-3. PubMed ID: 24850170
[TBL] [Abstract][Full Text] [Related]
6. The expression of Cathepsin L in oral lichen planus.
Kitkhajornkiat A; Rungsiyanont S; Talungchit S; Jirawechwongsakul P; Taebunpakul P
J Oral Biol Craniofac Res; 2020; 10(3):281-286. PubMed ID: 32612918
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Potential Risk Factors that contribute to Malignant Transformation of Oral Lichen Planus: A Literature Review.
Agha-Hosseini F; Sheykhbahaei N; SadrZadeh-Afshar MS
J Contemp Dent Pract; 2016 Aug; 17(8):692-701. PubMed ID: 27659090
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and diagnostic significance of p16, p53 expression in lichen planus as a potential premalignant lesion in oral squamous cell carcinoma.
Sridharan N; Nagalingam S; Vidhya P; Viswanathan P
J Oral Maxillofac Pathol; 2024; 28(1):56-61. PubMed ID: 38800439
[TBL] [Abstract][Full Text] [Related]
9. Role of tumor suppressor protein p16 in patients with oral lichen planus.
Hadzi-Mihailovic M; Stanimirovic D; Pasoski B
J BUON; 2020; 25(2):1193-1198. PubMed ID: 32521925
[TBL] [Abstract][Full Text] [Related]
10. Study of P21 Expression in Oral Lichen Planus and Oral Squamous Cell Carcinoma by Immunohistochemical Technique.
Baghaei F; Shojaei S; Afshar-Moghaddam N; Zargaran M; Rastin V; Nasr M; Moghimbeigi A
J Dent (Shiraz); 2015 Sep; 16(3):156-61. PubMed ID: 26331143
[TBL] [Abstract][Full Text] [Related]
11. Assessment of bax and bcl-2 immunoexpression in patients with oral lichen planus and oral squamous cell carcinoma.
Nafarzadeh S; Jafari S; Bijani A
Int J Mol Cell Med; 2013; 2(3):136-42. PubMed ID: 24551804
[TBL] [Abstract][Full Text] [Related]
12. Molecular Targeting of Her-2/neu Protein Is Not Recommended as an Adjuvant Therapy in Oral Squamous Cell Carcinoma and Oral Lichen Planus.
Kouhsoltani M; Aghbali A; Shokoohi B; Ahmadzadeh R
Adv Pharm Bull; 2015 Dec; 5(Suppl 1):649-52. PubMed ID: 26793611
[TBL] [Abstract][Full Text] [Related]
13. Oral lichen planus has a high rate of TP53 mutations. A study of oral mucosa in icelanD.
Ogmundsdóttir HM; Hilmarsdóttir H; Astvaldsdóttir A; Jóhannsson JH; Holbrook WP
Eur J Oral Sci; 2002 Jun; 110(3):192-8. PubMed ID: 12120703
[TBL] [Abstract][Full Text] [Related]
14. [The expression of EGFR in oral lichen planus, squamous cell papilloma and squamous cell carcinoma].
Zhao M; Fu XL; Lv H
Shanghai Kou Qiang Yi Xue; 2012 Dec; 21(6):673-6. PubMed ID: 23364554
[TBL] [Abstract][Full Text] [Related]
15. Bmi1 expression in oral lichen planus and the risk of progression to oral squamous cell carcinoma.
Ma L; Wang H; Yao H; Zhu L; Liu W; Zhou Z
Ann Diagn Pathol; 2013 Aug; 17(4):327-30. PubMed ID: 23639414
[TBL] [Abstract][Full Text] [Related]
16. Expression of hMSH2 protein of the human DNA mismatch repair system in oral lichen planus.
Pimenta FJ; Pinheiro MD; Gomez RS
Int J Med Sci; 2004; 1(3):146-151. PubMed ID: 15912193
[TBL] [Abstract][Full Text] [Related]
17. CD133 expression in oral lichen planus correlated with the risk for progression to oral squamous cell carcinoma.
Sun L; Feng J; Ma L; Liu W; Zhou Z
Ann Diagn Pathol; 2013 Dec; 17(6):486-9. PubMed ID: 23911820
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical Analysis of the Activation Status of the Akt/mTOR/pS6 Signaling Pathway in Oral Lichen Planus.
Prodromidis G; Nikitakis NG; Sklavounou A
Int J Dent; 2013; 2013():743456. PubMed ID: 24228033
[TBL] [Abstract][Full Text] [Related]
19. A Novel Approach to Differentiating Erosive and Reticular Lichen Planus Based on the Percentage of Dental Surfaces With Metal Restorations.
Zisis V; Giannakopoulos NN; Schmitter M; Poulopoulos A; Andreadis D
Cureus; 2023 Sep; 15(9):e44782. PubMed ID: 37809260
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of cell proliferation ratio in plaque and erosive oral lichen planus: An immunohistochemical study.
Redder CP; Pandit S; Desai D; Kandagal VS; Ingaleshwar PS; Shetty SJ; Vibhute N
Dent Res J (Isfahan); 2014 May; 11(3):316-20. PubMed ID: 25097640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
